This compound is a deuterium-labeled pharmaceutical intermediate used in the manufacturing process of alogliptin. Its structure features a pyrimidinedione core with a 3-aminopiperidinyl substituent and a benzonitrile group.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1133421-35-8
N-Desmethyl,N-2(2-cyanobenzyl) Alogliptin
analytical reference standard impurity
2-(Phenylthio)aniline
pharmaceutical intermediate for quetiapine
(6R,7R)-4-Methoxybenzyl 7-amino-3-(chloromethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride
pharmaceutical raw material
N-cyclohexylcyclohexanamine;5-fluoro-2-oxo-1H-pyrazine-3-carbonitrile
Pharmaceutical intermediate synthesis
N-Benzyloxycarbonylglycine
Protecting group reagent for peptide synthesis
Alogliptin (13CD3)
stable isotope labeled active pharmaceutical ingredient
(S)-Alogliptin Benzoate Salt
active pharmaceutical ingredient
Alogliptin
active pharmaceutical ingredient
2-[[6-[(3R)-3-aminopiperidin-1-yl]-2,4-dioxo-3-(trideuteriomethyl)pyrimidin-1-yl]methyl]benzonitrile
ZSBOMTDTBDDKMP-DDOHFVCQSA-N
[2H]C([2H])([2H])N1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)N
—